Stock 688266 SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Equities

688266

CNE100003RP1

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
55.3 CNY -0.14% Intraday chart for Suzhou Zelgen Biopharmaceuticals Co.,Ltd. +0.36% +4.46%
04-19 Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-12 Suzhou Zejing Topical Vitiligo Cream Gets NMPA's Nod for Clinical Trials MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Apeloa Pharma Forms Strategic Drug Alliance With Zelgen Biopharma
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
111 : Partners With Suzhou Zelgen to Develop Liver Cancer Patients Platform in China
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Announces Earnings Results for First Three Quarters of 2020
Suzhou Zelgen Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Half of 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688266 Stock
  4. News Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
  5. Other languages